Skip to Content
Print Save

Aqua-Ban with Pamabrom (pamabrom) Disease Interactions

There is 1 disease interaction with Aqua-Ban with Pamabrom (pamabrom):

Moderate

Pamabrom (applies to Aqua-Ban with Pamabrom) hypokalemia

Moderate Potential Hazard, Moderate plausibility.

The use of pamabrom (a theobromine derivative) has been associated with the renal elimination of potassium due to its diuretic effects. Therapy with pamabrom should be administered cautiously in patients with hypokalemia.

References

  1. "Product Information. Lozol (indapamide)." Rhone-Poulenc Rorer, Collegeville, PA.
  2. "Product Information. Minizide (prazosin-polythiazide)." Pfizer US Pharmaceuticals, New York, NY.
  3. "Product Information. Enduron (methyclothiazide)." Abbott Pharmaceutical, Abbott Park, IL.
  4. "Product Information. Exna (benzthiazide)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  5. "Product Information. Diucardin (hydroflumethiazide)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
  6. "Product Information. Thalitone (chlorthalidone)." Monarch Pharmaceuticals Inc, Bristol, TN.
  7. Niemeyer C, Hasenfub G, Wais U, et al "Pharmacokinetics of hydrochlorothiazide in relation to renal function." Eur J Clin Pharmacol 24 (1983): 661-5
View all 7 references

Aqua-Ban with Pamabrom (pamabrom) drug interactions

There are 18 drug interactions with Aqua-Ban with Pamabrom (pamabrom)

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer